Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Intimation of Schedule of Analyst/Institutional Investor Meeting
05-03-2024
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding issuance of Letter of confirmation in lieu of duplicate share certificate.
01-03-2024

Sun Pharma's Dilip Shanghvi Aims To Raise R&D Spend To $1 Billion NDTV Profit Exclusive

Dilip Shanghvi aspires to increase Sun Pharma's research and development spend to a billion dollars in the next three to five years.
28-02-2024
Bigul

Sun Pharma to acquire 16.33 per cent in Surgimatix Inc, for $ 3.05 million

The Illinois-headquartered company is engaged in developing a proprietary soft tissue fixation device for laparoscopic hernia repair and other minimally invasive surgeries
20-02-2024
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Acquisition

This is to inform that the Company (together with its subsidiaries) has entered into an agreement with Surgimatix Inc. pursuant to which the company has agreed to acquire 16.33% shares of Surgimatix Inc.
20-02-2024
Next Page
Close

Let's Open Free Demat Account